BiondVax Pharmaceuticals ...

NASDAQ: BVXV · Real-Time Price · USD
1.36
0.01 (0.74%)
At close: Sep 06, 2023, 9:59 PM

BiondVax Pharmaceuticals Cash Flow Statement

Financials in ILS. Fiscal year is January - December.
Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021
Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Net Income
6.73M 8.01M 775K -35.13M -34.27M -45.89M 20.18M -12.75M
Depreciation & Amortization
-359K -372K 84K 2.12M 1.94M 2.42M 2.45M 2.44M
Stock-Based Compensation
1.75M 2.04M 4.13M 6.66M 7.93M 8.79M 11.04M 11.84M
Other Working Capital
-1.44M -1.23M -638K 5.04M 1.1M 3.89M -71.62M -68.63M
Other Non-Cash Items
-1.33M -3.06M -1.6M -1.65M 234K -413K -1.39M 22M
Deferred Income Tax
-765K n/a -52K -48K -24K -27K 11K -2K
Change in Working Capital
-1.94M -764K -1M 3.78M 2.43M -1.43M -72.59M -69.49M
Operating Cash Flow
-490K 1.28M -2.18M -24.22M -21.73M -36.53M -40.32M -45.97M
Capital Expenditures
-917K -1.06M -1.35M -867K -929K -505K -3.56M -4.87M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-33K -33K 9K -7K 32K 450K 408K 425K
Investing Cash Flow
-950K -1.09M -1.34M -874K -897K -55K -3.15M -4.44M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
681K 681K 1.36M n/a n/a n/a -681K n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-26.28M -26.28M 988K 25.81M 25.96M 25.65M -1.76M 9.27M
Financial Cash Flow
-26.28M -26.28M 988K 25.81M 25.96M 25.65M -1.76M 9.27M
Net Cash Flow
-28.84M -27.53M -4.88M 158K 851K -12.52M -45.86M -41.78M
Free Cash Flow
-1.41M 220K -3.54M -25.09M -22.65M -37.03M -43.87M -50.83M